Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels Prior to Elective Surgery

NCT04263571 is registered in ClinicalTrials.gov with Goethe University as lead sponsor.

NCT NCT04263571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04263571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels Prior to Elective Surgery
Lead sponsor
Goethe University
Phase
Observational
Overall status
Unknown status
Start date
April 12, 2019
Completion date
December 31, 2023
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, iv iron